The Silent Killer: ASCVD – A Growing Epidemic

Atherosclerotic Cardiovascular Disease (ASCVD) is a silent killer, silently wreaking havoc on global health. This insidious condition, characterized by the buildup of plaque in your arteries, is a leading cause of heart attacks and strokes. Early detection is crucial, yet traditional methods often fall short.

The Cost of Inaction: The Human and Financial Toll of ASCVD

The consequences of undetected ASCVD are staggering. Not only does it lead to devastating health outcomes, such as heart attacks and strokes, but it also imposes a massive economic burden on healthcare systems worldwide. Delayed diagnosis can result in costly hospitalizations, prolonged treatments, and reduced quality of life.

Kribado: Your Solution to the ASCVD Challenge

Kribado is a groundbreaking risk stratification and behavior setting device designed to combat the ASCVD epidemic. By leveraging advanced algorithms and a user-friendly interface, Kribado empowers healthcare providers to identify patients at high risk of ASCVD with unmatched accuracy and efficiency.

This innovative solution offers a non-invasive screening protocol that instantly generates a risk score, enabling early intervention and improved patient outcomes. Kribado’s streamlined data collection process eliminates errors, ensuring reliable and actionable insights.

Indigital Technologies: Your Partner in Patient Care

Kribado is a testament to our dedication to transforming healthcare. With a vast library of over 200 COAs and expertise in 12 therapeutic areas, we are confident in our ability to deliver exceptional value to our clients.